Literature DB >> 1985897

DNA binding of purified transcription factor NF-kappa B. Affinity, specificity, Zn2+ dependence, and differential half-site recognition.

U Zabel1, R Schreck, P A Baeuerle.   

Abstract

A rapid purification procedure for the NF-kappa B transcription factor from the cytosol of human placenta is demonstrated which exploits the insensitivity of the NF-kappa B.DNA complex toward the intercalating agent chloroquine. Purified NF-kappa B required 100 mM KCl or NaCl and a pH of 7.5 to optimally bind to DNA. Equilibrium of binding was reached within less than 5 min in the absence of competitor DNA and after 1 h in the presence of 0.1 mg/ml poly(dI-dC). DNA binding of NF-kappa B was specifically blocked by the chelating agent 1,10-orthophenantroline and could only be reconstituted by addition of Zn2+. Under optimal binding conditions, the dissociation constant for the complex of the purified NF-kappa B with its most frequent cognate DNA motif 5'-GGGACTTTCC-3' was in the range of 10(-12) to 10(-13) M. Various other cis-acting kappa B motifs were recognized by NF-kappa B with lower affinities. A comparative analysis of known NF-kappa B-binding sites and competition experiments with synthetic polynucleotides and oligonucleotides encompassing only one half-site or single-stranded kappa B motifs suggested that the two DNA-binding monomers in the NF-kappa B protein complex can interact differentially with the half-sites of the decameric cognate motif.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985897

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  94 in total

1.  Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis.

Authors:  F Arnalich; E Garcia-Palomero; J López; M Jiménez; R Madero; J Renart; J J Vázquez; C Montiel
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.

Authors:  R P Nagarajan; F Chen; W Li; E Vig; M A Harrington; H Nakshatri; Y Chen
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

3.  Sequence-specific DNA binding by the MspI DNA methyltransferase.

Authors:  A K Dubey; R J Roberts
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

4.  DNA-binding properties of the E1A-associated 300-kilodalton protein.

Authors:  Y Rikitake; E Moran
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

5.  Transcription factor oscillations induce differential gene expressions.

Authors:  Keng Boon Wee; Wee Kheng Yio; Uttam Surana; Keng Hwee Chiam
Journal:  Biophys J       Date:  2012-06-05       Impact factor: 4.033

6.  Human alpha-galactosidase A: high plasma activity expressed by the -30G-->A allele.

Authors:  T F Fitzmaurice; R J Desnick; D F Bishop
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

7.  Developmental and tissue-specific expression of the Q5k gene.

Authors:  S Schwemmle; D Bevec; G Brem; M B Urban; P A Baeuerle; E H Weiss
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

8.  Identification of nucleophosmin as an NF-kappaB co-activator for the induction of the human SOD2 gene.

Authors:  Sanjit K Dhar; Bert C Lynn; Chotiros Daosukho; Daret K St Clair
Journal:  J Biol Chem       Date:  2004-04-15       Impact factor: 5.157

9.  Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site.

Authors:  I C Oliveira; N Mukaida; K Matsushima; J Vilcek
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

10.  Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B.

Authors:  J R Matthews; W Kaszubska; G Turcatti; T N Wells; R T Hay
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.